Sangamo Therapeutics Management
Management criteria checks 2/4
Sangamo Therapeutics' CEO is Sandy Macrae, appointed in Jun 2016, has a tenure of 6.42 years. total yearly compensation is $4.74M, comprised of 14.5% salary and 85.5% bonuses, including company stock and options. directly owns 0.091% of the company’s shares, worth €542.87K. The average tenure of the management team and the board of directors is 3.2 years and 3 years respectively.
Key information
Sandy Macrae
Chief executive officer
US$4.7m
Total compensation
CEO salary percentage | 14.5% |
CEO tenure | 6.4yrs |
CEO ownership | 0.09% |
Management average tenure | 3.2yrs |
Board average tenure | 3yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2022 | n/a | n/a | -US$178m |
Jun 30 2022 | n/a | n/a | -US$172m |
Mar 31 2022 | n/a | n/a | -US$176m |
Dec 31 2021 | US$5m | US$689k | -US$178m |
Sep 30 2021 | n/a | n/a | -US$181m |
Jun 30 2021 | n/a | n/a | -US$135m |
Mar 31 2021 | n/a | n/a | -US$124m |
Dec 31 2020 | US$4m | US$682k | -US$121m |
Sep 30 2020 | n/a | n/a | -US$76m |
Jun 30 2020 | n/a | n/a | -US$102m |
Mar 31 2020 | n/a | n/a | -US$96m |
Dec 31 2019 | US$4m | US$662k | -US$95m |
Sep 30 2019 | n/a | n/a | -US$118m |
Jun 30 2019 | n/a | n/a | -US$104m |
Mar 31 2019 | n/a | n/a | -US$90m |
Dec 31 2018 | US$4m | US$636k | -US$68m |
Sep 30 2018 | n/a | n/a | -US$63m |
Jun 30 2018 | n/a | n/a | -US$62m |
Mar 31 2018 | n/a | n/a | -US$58m |
Dec 31 2017 | US$2m | US$612k | -US$55m |
Sep 30 2017 | n/a | n/a | -US$51m |
Jun 30 2017 | n/a | n/a | -US$58m |
Mar 31 2017 | n/a | n/a | -US$72m |
Dec 31 2016 | US$4m | US$350k | -US$72m |
Compensation vs Market: Sandy's total compensation ($USD4.74M) is above average for companies of similar size in the German market ($USD1.11M).
Compensation vs Earnings: Sandy's compensation has increased whilst the company is unprofitable.
CEO
Sandy Macrae (59 yo)
6.4yrs
Tenure
US$4,735,817
Compensation
Dr. Alexander D. Macrae, also known as Sandy, M.B., Ch B, Ph D., MRCP, serves as an Independent Non-Executive Director of 4D pharma plc since August 27, 2019.Dr. Macrae has been the Chief Executive Office...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO, President & Director | 6.4yrs | US$4.74m | 0.091% $ 542.9k | |
Senior VP | 3.4yrs | US$1.06m | 0.015% $ 91.1k | |
Executive VP & COO | less than a year | US$1.66m | 0.034% $ 206.1k | |
Executive Vice President of Technical Operations | 3.2yrs | US$1.69m | 0.026% $ 158.6k | |
Senior VP & Chief Scientific Officer | 1.8yrs | no data | 0.023% $ 138.2k | |
Head of Corporate Communications & Investor Relations Officer | no data | no data | no data | |
Senior VP | 1.3yrs | no data | 0.016% $ 96.1k | |
Senior VP & Chief People Officer | 2.8yrs | no data | no data | |
Senior Vice President of Product Development & Management | 3.8yrs | no data | 0.015% $ 90.8k | |
Chief of Staff | 6.3yrs | no data | no data | |
Senior VP & Chief Medical Officer | 3.2yrs | no data | no data | |
Senior VP & Chief Quality Officer | 2.3yrs | no data | no data |
3.2yrs
Average Tenure
55yo
Average Age
Experienced Management: GBY's management team is considered experienced (3.2 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO, President & Director | 6.4yrs | US$4.74m | 0.091% $ 542.9k | |
Independent Chairwoman of the Board | 8.4yrs | US$298.06k | 0.022% $ 132.2k | |
Independent Director | 6.4yrs | US$273.06k | 0.014% $ 84.7k | |
Member of Scientific Advisory Board | 3yrs | no data | no data | |
Member of Scientific Advisory Board | 3yrs | no data | no data | |
Member of Scientific Advisory Board | 3yrs | no data | no data | |
Member of Scientific Advisory Board | 3yrs | no data | no data | |
Member of Scientific Advisory Board | 3yrs | no data | no data | |
Independent Director | 4.4yrs | US$264.94k | 0.016% $ 93.8k | |
Member of Scientific Advisory Board | 3yrs | no data | no data | |
Member of Scientific Advisory Board | 3yrs | no data | no data | |
Member of Scientific Advisory Board | 3yrs | no data | no data |
3.0yrs
Average Tenure
64.5yo
Average Age
Experienced Board: GBY's board of directors are considered experienced (3 years average tenure).